Mei Feng

1 clinical trials · Sponsor

Record	Firm	Date
A Prospective Study of the Early Treatment of Recombinant Human Thrombopoietin for Chemoradiation Induced Thrombocytopenia in Cervical Squamous Cell Carcinoma Patient (NCT07649395)	Mei Feng	2021-02-01

Every clearance here is in the API, with alerts when new ones post.